{
    "nctId": "NCT02122588",
    "briefTitle": "OVArian Cancer Non-Interventional Study - OVATAR",
    "officialTitle": "OVArian Cancer Non-Interventional Study. Treatment hAbits and Epidemiology of BRCA in Russian Federation - OVATAR",
    "overallStatus": "COMPLETED",
    "conditions": "Ovarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in Russia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 503,
    "primaryOutcomeMeasure": "Evaluation of 1st line chemotherapy treatment of serous and endometrioid ovarian, peritoneal and fallopian tube cancer (drugs by INN (International Nonproprietary Name), doses, regimen)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. The voluntary obtained informed consent signed by both the subject and the investigator.\n2. Confirmed serous and endometrioid ovarian cancer or fallopian tube cancer or peritoneal cancer diagnosed 3 months before enrolment into the study or later\n3. Patients on treatment for OC (Ovarian Cancer) or FTC (Fallopian Tube Cancer) or PC (Peritoneal Cancer)\n\nExclusion Criteria:\n\n1. The ovarian cancer histology other than serous and endometrioid.\n2. Patients participating in clinical studies.\n3. Any medical condition which on the opinion of the investigator may interfere the patient's participation in the trial.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}